E1-deleted adenovirus (Ad) vectors expressing the human to the induction of a cellular immune response to the lacZ coagulation factor IX (hFIX) or the bacterial ␤-galactoantigen. In contrast, absence of detectable levels of serum sidase (lacZ) were injected intravenously into various hFIX in immunocompetent animals was not associated with strains of immunocompetent (C57Bl/6, BALB/c, CD1, a loss of viral DNA but was strictly correlated with the CBA/J, C3H) and immunodeficient (BALB/c-nu/nu, induction of anti-hFIX antibodies. Surprisingly, anti-hFIX C57Bl/6-nu/nu, SCID, NIH-bg-nu-xid) mice. Regular analyantibodies were never detected in C57Bl/6 mice, leading sis of mouse sera and tissues showed a persistent to prolonged detection of hFIX. These results suggest that expression of both transgenes in immunodeficient mice, cellular immunity to viral antigens plays a minor role in the while detection diminished very rapidly in immunocompetearly extinction of transgene expression and illustrate the ent mice. The mechanisms responsible for the transient influence of the cellular (eg lacZ) or humoral (eg hFIX) detection of the two transgenes were however not identimmunity to transgene-encoded products on the persistical. Rapid decline of lacZ expression was correlated with a ence of transgene expression. rapid decrease of viral DNA sequences, and consequently
Introduction
vectors in that expression of the transgene in the transHuman adenoviruses (Ad) are attractive candidate vecduced tissues was found in most cases to be only transitors for the direct in vivo transfer of potential therapeutic ent. [14] [15] [16] 18, 21 These experiments suggested that the shortor vaccinal genes. [1] [2] [3] They are usually associated with lived in vivo expression of the transgenes was most probbenign pathologies in humans, the organization of their ably related to the induction of a host-specific cytotoxic 36-kb double-stranded DNA genome is well estab-T lymphocyte (CTL) immune response directed against lished 4, 5 and various methods for the generation of viral antigens synthesized at low levels in the transduced recombinant vectors are available. [6] [7] [8] [9] [10] Most current adentissues. [26] [27] [28] [29] [30] [31] [32] [33] [34] ovirus vectors are derived from the Ad type 5 (Ad5) virus Until very recently, the majority of published animal in which a foreign expression cassette has been introstudies were, however, performed with adenovirus vecduced in place of the early region 1 (E1). Such E1-deleted tors expressing bacterial or human proteins. It is now vectors can be easily produced at high titers in compclear that these proteins also constitute potential antigens lementation cell lines providing the E1 functions in recognized as foreign by the host immune system. In a trans. 11, 12 The deletion of the regulatory E1 genes prevents recently published study, Tripathy et al 35 observed that viral propagation in infected organisms and dramatically administration to immunocompetent mice of vectors reduces the expression of all viral genes. [1] [2] [3] 13 Further encoding the murine erythropoietin resulted in long-lastdeletion of the nonessential early region 3 (E3) genes ing elevated hematocrit levels. In contrast, injection of allows insertion of larger segments of foreign DNA (up adenoviruses carrying the human erythropoietin gene to 8 kb) in the viral genome. Such E1/E3-deleted vectors induced a strong immune response directed against the have already been used to transduce in vivo a wide range human protein, which resulted in a transient expression of both proliferating and quiescent cells with no, or limof the transgene. The use of a broad range of transgenes ited, side-effects [14] [15] [16] [17] [18] [19] [20] [21] [22] and adenovirus-mediated gene from various origins may therefore strongly disturb the transfer is currently considered for the genetic treatment accurate determination of the specific immunological facof cystic fibrosis. 23 coding for immunogenic proteins. Also, most in vivo studies were done using inbred mouse strains of various h). In all animals (n = 23), hFIX values reached a peak level of 100 to 1000 ng/ml within 2 days of infection but haplotypes whose immune systems might react differently to a given antigen. Barr et al 39 reported that intrarapidly decreased to undetectable levels in BALB/c, CBA/J, CD1 or C3H mice 1 month after virus injection venous administration of an E1-deleted adenovirus vector carrying the human alpha-antitrypsin (h␣-AT) cDNA ( Figure 1a ). The pattern of hFIX expression was surprisingly different in C57Bl/6 mice (n = 6). After a similar leads to a strain-related variation in the persistence of expression of the transgene. The authors suggested that initial peak 2 days after inoculation, hFIX remained relatively persistent in the plasma during the course of the these variations were related to unidentified genetic loci that might influence the antigen-specific immune study. Despite a progressive decline, a concentration of 50 ng/ml of hFIX (around 5% of the peak value) was still response. They did not however precisely determine the immunological factors responsible for the transient detectable as late as 111 days after virus injection. A similar persistence of hFIX expression in C57Bl/6 mice only expression of h␣-AT in C3H/HeJ and BALB/c mice and the longer persistence of expression in C57Bl/6 mice.
has already been described in a previous report 21 but no precise correlation with any biological or immunological In this article, we report a similar strain-related variation of transgene expression in mice injected intracomponent was identified. In contrast to hFIX, expression of ␤-galactosidase was transient in all immunocompetent venously with a recombinant adenovirus carrying the human coagulation FIX (hFIX) cDNA and we describe mice injected with AdLacZ (n = 25). LacZ expression was detected in livers and lungs only during the first 3 weeks the immunological component involved in the persistence of hFIX expression. We also investigated in nine difafter virus inoculation (Figure 2c . In all mice (n = 18), serum hFIX concentration increased rapidly to reach a peak value 2 Persistence of hFIX and lacZ expression in immunocompetent mice days after treatment, and then remained relatively stable during the course of the study. Similar to C57Bl/6 mice, Recombinant AdhFIX and AdLacZ vectors (5 × 10 9 p.f.u.) were injected into the tail vein of inbred C57Bl/6, a slight progressive decrease of hFIX levels was none the less observed in all immunodeficient animals suggesting BALB/c, CBA/J, C3H and outbred CD1 mice. Sera and tissues (liver and lung) were then regularly collected and that nonimmunological factors (eg natural cell turn-over) are involved in this slow decline of transgene expression. tested by ELISA for hFIX concentration ( 
Lungs (a and e) and livers (b and f) from SCID mice, livers from BALB/c mice (c and g) and lungs from C57Bl/6 mice (d and h) were recovered 10 days (a-d) or 60 days (e-h) after virus inoculation and were tested by X-gal staining for ␤-galactosidase expression.
mice (except C57Bl/6) in which hFIX levels diminish preanimals ( Figure 4 ). As expected, no anti-adenovirus or anti-hFIX antibodies were detected in the sera of cipitously (see above). Similarly to results with hFIX, and in agreement with previous reports, [29] [30] [31] [32] [33] lacZ expression immunodeficient mice. In parallel, lungs and livers were regularly recovered from C57Bl/6, BALB/c and NIH-bgin liver, lung and heart recovered from mice injected with AdLacZ was stable in all immunodeficient animals (n = nu-xid mice (three to six animals per strain) injected with AdhFIX and total DNA was prepared and analyzed for 16): 25% (mean ± 5%) of the liver cells stained positive for lacZ expression from day 4 to day 60 after intravenous vector DNA persistence ( Figure 5a ). No significant difference in the persistence of AdhFIX DNA in liver (Figure injection of AdLacZ. In contrast, no lacZ-positive cells were found in immunocompetent mice (n = 25) 60 days 5a) and lung (data not shown) was found between BALB/c and C57Bl/6 animals indicating that prolonged after virus inoculation ( Figure 2 ). These observations suggest that a host-specific immune response is involved in detection of hFIX in the serum of C57Bl/6 mice is not related to a better stability of vector DNA or a longer the rapid disappearance of hFIX and lacZ expression in these animals. The mechanisms responsible for the transipersistence of the transduced cells in this mouse strain. These results suggest that the rapid disappearance of ent expression of lacZ and hFIX in immunocompetent mice are however probably not the same since hFIX hFIX detection in immunocompetent mice (except C57Bl/6) is a consequence of the induction of specific expression is persistent in C57Bl/6 but not in CD1, BALB/c, CBA/J and C3H mice, while lacZ expression is antibodies against the human protein. transient in all tested immunocompetent animals.
Loss of hFIX detection correlates with the induction of
Extinction of lacZ expression correlates with the disappearance of AdLacZ DNA anti-hFIX antibodies In order to determine the immunological factor(s) responAlthough the pattern of hFIX and lacZ expression is apparently similar in all animals except C57Bl/6 mice, sible for the decline in hFIX expression, serum samples were recovered from C57Bl/6, BALB/c, CBA/J, C3H, the mechanisms responsible for the absence of persistence of lacZ and hFIX expression in immunocompetent CD1, nu/nu and NIH-bg-nu-xid mice injected with AdhFIX and were tested by ELISA for the presence of mice are however not identical. Analysis of viral DNA copy number in liver and lung recovered from BALB/c, antibodies directed against either adenovirus (Figure 3 ) or the human transgene (Figure 4) . Analysis of these sera C57Bl/6 and SCID mice (three to six animals per strain) at 3 and 45 days after AdLacZ inoculation revealed a revealed a strong correlation between hFIX expression and induction of anti-hFIX antibodies. While anti-adenostriking difference between the two types of vectors ( Figure 5 ). Despite a progressive decline, AdhFIX DNA virus neutralizing antibodies were detected in the sera recovered from all immunocompetent mice (Figure 3) , copy number was still relatively high in all tested immunocompetent animals 48 days after virus injection (over high levels of anti-hFIX antibodies were found only in BALB/c, C3H, CBA/J and CD1 mice but not in C57Bl/6 one copy per cell) showing good in vivo stability of aden- ovirus DNA in quiescent murine cells (Figure 5a ). In conduced cells (C57Bl/6, CBA/J and C3H mice) and prolonged detection of the transgene expression (C57Bl/6 trast to AdhFIX, AdLacZ sequences declined very rapidly in both liver and lung tissues (Figure 5b , and data not mice) similarly developed a CTL response against the viral antigens. In agreement with Yang et al, [29] [30] [31] [32] [33] a strong shown) to reach undetectable levels at 45 days after virus injection. Similarly to AdhFIX, AdLacZ DNA was howvirus-specific CTL response was detected in all (n = 6) tested animals (Figure 6a and c; data not shown), indeever relatively stable in organs isolated from immunodeficient mice (Figure 5b ). Altogether, these observations pendently of the pattern of expression of the transgene. The development of a cellular immune response specifisuggest that AdLacZ DNA is rapidly eliminated as a result of the host immune reaction. In contrast, persistcally directed against the adenovirus antigens was further confirmed by experiments showing that AdLacZ ence of AdhFIX DNA, but not persistence of hFIX detection, is less sensitive to immunological factors. viral particles can specifically stimulate the proliferation of spleen cells recovered from mice inoculated by AdhFIX (Figure 6b and d) . However, in contrast to preAdenovirus-specific cytotoxic T lymphocytes (CTLs) are not involved in the rapid elimination of the AdLacZ vious reports, [29] [30] [31] [32] [33] these data indicate that the induction of a cytotoxic cellular immune reaction directed against transduced cells The in vivo persistence of AdhFIX genomic DNA was adenovirus antigens does not directly lead to a rapid destruction of the transduced cells. Furthermore, these unexpected given previous reports showing the induction of adenovirus-specific CTLs in mice injected with results also suggest that the rapid elimination of the AdLacZ-transduced cells (Figure 5b) is not related to the vectors expressing the bacterial ␤-galactosidase or alkaline phosphatase genes. [29] [30] [31] [32] [33] These observations led to the presence of anti-adenovirus CTLs, but most probably to a CTL response directed against the ␤-galactosidase, as suggestion that the virus-specific cellular immune response was responsible for the rapid destruction of the we have previously reported. 40 We cannot however completely exclude that the apparent slow decline of AdhFIX transduced cells. In order to determine more precisely the role of the anti-adenovirus cellular immunity, we tested DNA copy number observed in the immunocompetent mice is a long-term consequence of the anti-adenovirus whether immunocompetent mice inoculated with AdhFIX that display long-term persistence of the trans-CTL reaction (Figure 5a ). 
u. of AdhFIX (circles) or PBS (squares). Splenocytes were restimulated in vitro for 6 days with either L929 (a) or EL-4 (c) cells infected with AdLacZ at a multiplicity of infection (MOI) of 200, and were tested for specific lysis on AdLacZ-infected L929 or EL-4 target cells, respectively. In parallel, splenocytes from mock-infected (filled bars) or AdhFIX-infected (cross-hatched bars) C3H (b) and C57Bl/6 (d) mice were analyzed for their T cell proliferative response to 10
4 and 10 6 AdLacZ adenovirus particles coated on the culture plates.
vectors simultaneously deleted in E1 and E4 have there-
Discussion
fore been recently generated in order to abolish the The prospect of using E1-deleted adenovirus vectors to expression of viral antigens. [36] [37] [38] transfer potential therapeutic genes into a variety of In order to establish the optimal parameters required quiescent and dividing cell types in the absence of for a comparative in vivo evaluation of first generation residual expression of viral genes stimulated a broad E1-deleted adenovirus vectors (E1°) and second generinterest in the possible treatment of a number of genetic ation (E1°/E2A°, E1°/E4°, E1°/E2A°/E4°) vectors, we diseases.
14-25 Recent data from in vivo studies in various tested the influence of the mouse strain and the nature animal models have however revealed that in most cases, of the transgene on the persistence of expression in mice only transient expression of the transgenes was treated with recombinant E1-deleted vectors. Experiobtained.
14-16,18,21 Despite the deletion of E1, current vecments were performed using nine differents strains of tors still express viral genes encoding early (DNA bindimmunocompetent and immunodeficient mice and two ing protein) and late proteins (penton, hexon, fiber) at E1-deleted adenovirus vectors expressing the human low levels (Refs 26-33; our unpublished data), suggesting coagulation factor IX or the bacterial ␤-galactosidase that such proteins might be recognized as foreign by the genes. immune system of the treated subjects, leading to As previously reported for human and canine FIX and immunological destruction of the transduced cells.
human ␣-AT, 15,21,39 we confirm that the animal strain sigRecent reports showing prolonged expression in animals nificantly influences the apparent persistence of hFIX treated with adenovirus vectors defective in both E1 and expression. We extend these observations with the identi-E2A and expressing no, or only low amounts, of viral fication of the immunological factor responsible for the proteins confirmed this initial hypothesis.
27,28,32 Novel transient persistence of hFIX in the immunocompetent mice tested in this study, with the exception of C57Bl/6. DNA copy number were detected 48 days after virus injection in the liver of BALB/c and C57Bl/6 mice, All immunocompetent animals, except C57Bl/6 mice, injected intravenously with the AdhFIX vector were respectively, while 80% of the initial DNA copy number was found in the liver of NIH-bg-nu-xid mice. Whether found to develop high levels of anti-hFIX antibodies within 15 days of treatment. These levels, ranging from this progressive diminution of the AdFIX DNA is the consequence of the induction of CTLs directed against 3 g/ml to 64 g/ml, are significantly higher than the background levels (Ͻ0.3 g/ml) observed in mockthe adenovirus antigens remains to be determined. The weak (or absence of) effect of the anti-adenovirus CTLs injected mice and were found to be inversely correlated with the persistence of hFIX in the serum of the animals.
on the persistence of the transduced cells also indicates that the rapid loss of the AdLacZ sequences that occurred Therefore, induction of anti-hFIX antibodies at levels that are above a threshold of about 1 g/ml seems to be assobetween 3 and 45 days in the hepatocytes and pulmonary cells of BALB/c and C57Bl/6 mice, but not in immunociated with a loss of detection of hFIX in the serum. As expected, none of the immunodeficient mice developed deficient mice, reflects the induction of a specific immune response directed against the lacZ transgene. We recently anti-hFIX antibodies and, similarly to the C57Bl/6 mice, presented a stable pattern of hFIX expression. Absence of demonstrated that administration of AdLacZ to BALB/c mice could induce a strong specific cellular and humoral production of anti-hFIX antibodies in C57Bl/6 animals was not related to an inability of the mice to develop a response directed against the ␤-galactosidase protein. 40 The specific anti-␤-galactosidase CTLs are most probably humoral response since all treated C57Bl/6 animals produced high levels of neutralizing antibodies directed responsible for the rapid decline in AdLacZ DNA copy number in the tissues of the treated animals, through the against the adenovirus particles. The absence of detection of hFIX in mice that develop anti-hFIX antibodies could destruction of lacZ-expressing cells.
Altogether our results show that: (1) persistence of be explained by at least two hypotheses: (1) anti-hFIX antibodies may participate in the formation of immune transgene expression in adult immunocompetent mice injected with E1-deleted recombinant adenovirus vectors complexes with the secreted hFIX. The presence of such complexes may block the detection of the hFIX by ELISA, is much better than previously suggested, 15,26-33 provided that the animals are tolerant to the protein encoded by or may facilitate the elimination of the circulating hFIX molecules; (2) these antibodies may trigger an antibodythe transgene (eg hFIX in C57Bl/6 mice). This observation confirms recent data generated with an E1-deleted dependent cell cytotoxicity 41 (ADCC) leading to destruction of the transgene-expressing cells. Analysis of the adenovirus encoding the murine erythropoietin gene; 35 (2) the mouse strain selected for the study does influence AdhFIX DNA copy number in various tissues recovered from the injected mice does not support the latter hypoththe pattern of detection or expression of the transgene, depending on the ability of the animal to develop an esis: viral DNA was always relatively stable during the course of our study, indicating that the transduced hepaimmune response against the transgene product. Moreover, the type of immune response elicited in the treated tocytes or pulmonary cells were not rapidly eliminated in any of the treated mice. The first hypothesis is further animals (humoral versus cellular) also significantly influences the persistence of the transduced cells: loss of lacZ supported by the detection over 2 months of hFIXspecific RNAs in organs recovered from the immunocomexpression is correlated with an elimination of the transduced cells, while loss of hFIX detection is not; (3) consepetent mice (data not shown).
Interestingly, all tested immunocompetent mice quently, the nature of the selected transgene might significantly alter the conclusions of the study regarding the injected with AdhFIX developed a cytotoxic cellular immune response directed specifically against the adenrespective roles of the adenovirus-specific and transgenespecific immunological factors in the persistence of transovirus antigens. However, these CTLs were not sufficient to induce a rapid elimination of the transduced liver and gene expression; (4) although the administration of recombinant adenoviruses induces a detectable cellular lung cells, as demonstrated by the relative stability of the AdhFIX DNA copy number in these tissues. This obserimmunity to the viral antigens, the transduced cells persist during a relatively long period of time (over 2 vation contradicts results published by Yang et al [29] [30] [31] [32] [33] indicating that cellular immunity to viral antigens constimonths; this work and data not shown). This observation suggests that the use in previous studies of adenoviruses tutes the dominant factor responsible for the rapid elimination of the transduced cells and hence for extinction encoding transgenes of various nonmurine origins might have led to an overestimation of the role of anti-adenoof transgene expression. The reason for this discrepancy remains unclear, but we cannot exclude the possibility virus CTLs in the transient expression of the transgenes in mice. This study also indicates that any future comthat the accumulation of high concentrations of foreign immunogenic proteins (eg ␤-galactosidase) activates the parison of the recently developed novel generations of adenovirus vectors should be done with vectors that do immune system and stimulates the development of a stronger specific immune reaction directed against the not express foreign genes or with animal models tolerant to the products encoded by the transgenes. virus antigens. It is also possible that the inflammatory reaction often associated with the use of first generation adenovirus vectors might potentiate the immune
Materials and methods
response directed against the transgene-encoded products. Such synergistic effects remain however to be experimentally demonstrated.
Animal studies Immunocompetent and immunodeficient female mice Compared with immunocompetent mice, an apparent better stability of AdhFIX DNA was nonetheless were purchased at 4 weeks of age from Iffa Credo were successively incubated for 2.5 h at room temperature with 100 l per well of diluted murine sera (1:50), 1 CD1, outbred) and immunodeficient [42] [43] [44] (BALB/c-nu/nu and C57Bl/6-nu/nu; C.B17-scid/scid; NIH-bg-nu-xid) h with 100 l per well of a biotin-SP-conjugated goat antimouse IgG + IgM (H+L) antibody (dilution 1:1000; Jackanimals were bred in a specific pathogen-free environment. 5 × 10 9 p.f. 11 between a plasmid DNA fragment containing the hFIX cDNA 45 under measured at 490 nm. Anti-hFIX antibody concentrations were determined using a characterized anti-hFIX monothe control of the mouse phosphoglycerate kinase promoter 46 (PGKpro), and the genomic ClaI DNA fragment clonal antibody (Sigma) as an internal standard. isolated from the H5dl324 virus. 22 The recombinant virus was plaque-purified and amplified on 293 cells, and virus
Quantitative analysis of viral DNA in mouse tissues Mice injected intravenously with 5 × 10 9 p.f.u. of AdhFIX genome integrity was analyzed by restriction enzyme digestion and Southern blot analysis. 47, 48 The E1/E3-or AdLacZ were killed 3 days, 2 weeks and 7 weeks after virus injection. Total cellular DNA was prepared from deleted AdLacZ vector used in this study has been previously described. liver or lung by SDS-proteinase K cell lysis followed by phenol-dichloromethane extraction and ethanol precipitation. Ten micrograms of DNA were digested by BamHI Determination of human factor IX (hFIX) concentration Concentration of human factor IX protein in mouse sera (AdhFIX) or EcoRV (AdLacZ) and analyzed by Southern blot 47 using appropriate 32 P dCTP-labelled DNA probes was determined using a commercial enzyme-linked immunosorbent assay (ELISA) (Asserachrom IX: Ag kit; (the hFIX cDNA or the ␤-galactosidase gene). A densitometry scanning of the autoradiographs was performed Diagnostica Stago, Asnières, France).
with the model GS-700 Imaging Densitometer (BioRad, Ivry-sur-Seine, France); the data were analyzed using the Anti-adenovirus antibody assay Concentrations of adenovirus-specific antibodies were Molecular Analyst/PC software (BioRad). determined by ELISA. Briefly, 96-well plates were coated overnight at 4°C with 50 l of buffer (200 mm NaHCO 3 , X-gal histochemistry Tissues recovered from killed mice were fixed at 4°C in 81 mm Na 2 CO 3 , pH 9.5) containing 1.6 × 10 7 p.f.u. of AdLacZ. Wells were then successively washed five times Cytotoxic T lymphocyte (CTL) assay Six-week-old female C57Bl/6 and C3H mice were immuAbsorbance was measured at 490 nm.
nized at day 0 and 10 with two intraperitoneal injections of 5 × 10 8 p.f.u. of AdhFIX in 100 l saline. Negative conNeutralizing anti-adenovirus antibody assay Determination of anti-adenovirus neutralizing antibodies trol mice were mock-infected with PBS in parallel. All mice were killed at day 14 and splenocytes from two was done as described previously 40 using decomplemented mouse sera.
immunized animals were pooled and stimulated in vitro Cr (Amersham) for 1 h at 37°C. Effector splenocytes NaHCO 3 , 81 mm Na 2 CO 3 , pH 9.5. Plates were then saturated with 250 l of a 3% BSA in PBS for 1 h at 37°C and were plated at different effector-to-target ratios (50:1,
